Rapport Therapeutics, Inc. (RAPP) Operating cash flow 2023–2025
Rapport Therapeutics, Inc. (RAPP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$87.5MFY2025 · since FY2023: -$27.2M → -$87.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$87.5M | -34.9% |
| FY2024 | -$64.8M | -138.5% |
| FY2023 | -$27.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RAPP financial trends
RAPP RevenueRAPP Net incomeRAPP Net marginRAPP Gross profitRAPP Gross marginRAPP Operating incomeRAPP Operating marginRAPP Free cash flowRAPP Capital expendituresRAPP Return on equityRAPP Stock buybacksRAPP Dividends paidRAPP Total assetsRAPP Total liabilitiesRAPP Shareholders’ equityRAPP overview →